Dosecann get Dealer's License & the global market beckons

Auxly Cannabis Group's (CBWTF) subsidiary, Dosecann, has obtained a Dealer's License for Controlled Drugs and Substances from Health Canada for Dosecann's purpose built 42,000 squa...

GW Pharmaceuticals releases Q3 results

Q3 financial results - Operational HighlightsGW Pharmaceuticals (GWPH) released third quarter financial results for the period that ended on June 30th.Epidiolex (cannabidiol)Regula...

Wrigley Bets on The Green Rush

Following on from the news that Molson Coors had entered the cannabis industry in a joint venture with The Hydropothecary Company last week, marijuana investments got another shot ...

CannTrust Accelerates Apotex Relationship

CannTrust accelerates their pharmaceutical strategyCannTrust Holdings (CNTTF) is accelerating its exclusive partnership with Apotex, the largest Canadian-owned generic pharmaceutic...

Canopy brings CHI in house and looks after man's best friend

Canopy Health Innovations brought in-houseCanopy Growth (CGC) completed the previously announced acquisition of Canopy Health Innovations Inc. (CHI), including the subsidiary opera...

Aurora Grows its Recreational Reach

Aurora Cannabis (ACBFF) and Alcanna (LQSIF) reached a license agreement whereby Alcanna has been given exclusive rights to open retail cannabis stores under the brand name Aurora a...

Aphria brings We Grow to the recreational market

Aphria (APHQF) signed a manufacturer's representative agreement with We Grow BC, a Vancouver-based licensed producer of premium cannabis, to become the exclusive sales representati...

Creso Pharma Cracks the Middle East With SuperMedic

Medical cannabis company Creso Pharma has announced further progress on its path of gradual growth and expansion with this morning's news that it has strengthened its market presen...

MPX Continues to Impress with Their 2018 Results

MPX Bioceutical Corporation reported its Full Year 2018 financial results.Following the acquisition of its first two dispensaries in Arizona, which operate under the Health for Lif...

CV Sciences Crush Their 2018 Financial Results

CV Sciences reported second quarter 2018 financial results.Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 Million."C...